Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Movement Disorders : Official Journal of the Movement Disorder Society|June 29, 2023
Detection of a Parkinson's Disease-Specific MicroRNA Signature in Nasal and Oral SwabsPatricia Schließer, Felix L Struebing, Bernd H Northoff, et al.
Cell Death & Disease|July 11, 2018
Exosomal secretion of α-synuclein as protective mechanism after upstream blockage of macroautophagyNatascha Fussi, Matthias Höllerhage, Tasnim Chakroun, et al.
Plos One|September 3, 2011
In vivo induction of Tr1 cells via mucosal dendritic cells and AHR signalingHenry Yim Wu, Francisco J Quintana, Andre Pires da Cunha, et al.
Molecular Neurodegeneration|May 12, 2023
Neuropathology of incidental Lewy body & prodromal Parkinson's diseaseThomas Koeglsperger, Svenja-Lotta Rumpf, Patricia Schließer, et al.
Molecular Neurobiology|April 23, 2022
Binding Stability of Antibody-α-Synuclein Complexes Predicts the Protective Efficacy of Anti-α-synuclein AntibodiesMatthias Höllerhage, Andreas Wolff, Tasnim Chakroun, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 6, 2026
Patient-Reported Feedback Suggests an Alternative Sweet Spot for Deep Brain Stimulation Programming in Essential TremorSophia Peschke, Jing Dong, Angelina Kirschner, et al.
Journal of Neurology|February 22, 2025
Invasive therapies for Parkinson's disease: an adapted excerpt from the guidelines of the German Society of NeurologyRené Reese, Thomas Koeglsperger, Christoph Schrader, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 21, 2020
Fibroblast Growth Factor 2-Mediated Regulation of Neuronal Exosome Release Depends on VAMP3/Cellubrevin in Hippocampal NeuronsRohit Kumar, Qilin Tang, Stephan A Müller, et al.
Scientific Reports|September 15, 2017
Protective efficacy of phosphodiesterase-1 inhibition against alpha-synuclein toxicity revealed by compound screening in LUHMES cellsMatthias Höllerhage, Claudia Moebius, Johannes Melms, et al.
Pageof 4